Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure.
Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure.
复制标题
慢性心力衰竭中压力感受器和迷走神经传入输入对心脏交感传入反射和交感活动的抑制
DOI:
10.1371/journal.pone.0025784
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Zhu GQ
中科院分区:
文献类型:
--
作者:
Gan XB;Duan YC;Xiong XQ;Li P;Cui BP;Gao XY;Zhu GQ
Background Cardiac sympathetic afferent reflex (CSAR) contributes to sympathetic activation and angiotensin II (Ang II) in paraventricular nucleus (PVN) augments the CSAR in vagotomized (VT) and baroreceptor denervated (BD) rats with chronic heart failure (CHF). This study was designed to determine whether it is true in intact (INT) rats with CHF and to determine the effects of cardiac and baroreceptor afferents on the CSAR and sympathetic activity in CHF. Methodology/Principal Findings Sham-operated (Sham) or coronary ligation-induced CHF rats were respectively subjected to BD+VT, VT, cardiac sympathetic denervation (CSD) or INT. Under anesthesia, renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded, and the CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Either CSAR or the responses of RSNA, MAP and CSAR to Ang II in PVN were enhanced in CHF rats treated with BD+VT, VT or INT. Treatment with VT or BD+VT potentiated the CSAR and the CSAR responses to Ang II in both Sham and CHF rats. Treatment with CSD reversed the capsaicin-induced RSNA and MAP changes and the CSAR responses to Ang II in both Sham and CHF rats, and reduced the RSNA and MAP responses to Ang II only in CHF rats. Conclusions The CSAR and the CSAR responses to Ang II in PVN are enhanced in intact CHF rats. Baroreceptor and vagal afferent activities inhibit CSAR and the CSAR responses to Ang II in intact Sham and CHF rats.
登录
查看更多内容
影响因子:
3.7
作者:
Dans AL;Teo K;Gao P;Chen JH;Jae-Hyung K;Yusoff K;Chaithiraphan S;Zhu J;Lisheng L;Yusuf S;Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Investigators
通讯作者:
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Investigators
影响因子:
8.3
作者:
Malliani, A;Montano, N
通讯作者:
Montano, N
DOI:
10.1152/ajpheart.00958.2008
发表时间:
2008-12-01
影响因子:
4.8
作者:
Yoshimoto, Misa;Wehrwein, Erica A.;Osborn, John W.
通讯作者:
Osborn, John W.
影响因子:
18.2
作者:
Han, Ying;Shi, Zhen;Zhu, Guo-Qing
通讯作者:
Zhu, Guo-Qing
影响因子:
3.3
作者:
Gao, Lie;Pan, Yan-Xia;Wang, Wei
通讯作者:
Wang, Wei